登录

Singular Medical Bags over $10M in Series A Funding Round

作者: Mailman 2020-03-20 12:36
无双医疗
http://www.singularmedical.net/
企业数据由 动脉橙 提供支持
心律管理产品研发、生产和销售商 | B+轮 | 运营中
中国-江苏
2023-01-06
融资金额:数亿人民币
荷塘创投
查看

According to 36Kr.com, Suzhou Singular Medical Co., Ltd. ("Singular Medical") has closed the Series A financing worth over tens of millions of dollars, led by Qiming Venture Partners, with participation from existing shareholders Northern Light Venture Capital, Marathon Venture Partners, and SND Ventures Group. 


Proceeds of this round will mainly be used for the small-batch production of ICD (Implantable Cardioverter Defibrillator) and the early clinical trials, and the R&D of CRM (Cardiac Rhythm Management) products. Previously, Singular Medical also obtained the investment from Northern Light Venture Capital, Marathon Venture Partners, SND Ventures Group, Zhen Fund, and CAS Star.


Established in 2017, Singular Medical is a new high-tech company specializing in R&D, production, and sales of various types of cardiac products, including ICD, pacemaker, and ICM (Implantable Cardiac Monitor). Its head office is located in the Medpark in Suzhou with clean rooms of 2800 square meters, and two R&D centers are set in Beijing and Irvine (USA) respectively.


Having gathered talents from different fields, such as electronics, chips, software, and structural design, Singular Medical is devoted to providing a complete range of solutions (from detection to follow-up) for large amounts of cardiac patients.


>>>>

About Qiming Venture Partners


Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Shenzhen, Hong Kong, Seattle, Boston, and San Francisco Bay Area. Currently, Qiming Venture Partners manages seven US Dollar funds and five RMB funds with over US$4 billion assets under management. Qiming Venture Partners invests in information technology, new consumer business patterns, and the healthcare sector.


>>>>

About Northern Light Venture Capital (Northern Light)


Founded in 2005, Northern Light is a venture capital firm targeting early-stage opportunities of innovation and disruptive technology. It has 5 RMB funds and 5 USD funds with managed capital of 4.5 billion dollars. Northern Light focuses on 3 main sectors including TMT, advanced technology, and healthcare covering medical devices, E-health and so on.

相关赛道 心血管耗材
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

MicroMedTec Closes on¥10M Pre-A Round, with its Aneurysm Sealing Product into Clinical Trails

Minkang Bio Closes ¥150M Pre-IPO Funding Round

Saints&Sages Snares $1.4M in Pre-A Round of Financing, Focusing on the Development of Minimally Invasive Equipment

BiomeSense完成200万美元种子轮融资,开发肠道微生物组跟踪工具

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

Sainuo Biology Completes Pre-A Financing Round, Led by BGI Co-win

2020-03-20
下一篇

中国东信与圆心科技合资,共同打造中国-东盟医疗信息港

2020-03-20